Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Twitterchats as a means to educate patients with CRC and caregivers and stimulate collaborations.
Authors
Manju George
Patient Advocate, Omaha, NE;
Manju George , Aparna Raj Parikh , Jonathan M. Loree , Nina Niu Sanford , Krishan Jethwa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Other
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 255)
DOI
10.1200/JCO.2023.41.4_suppl.255
Abstract #
255
Poster Bd #
N17
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2024 ASCO Annual Meeting
Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC).
First Author: Celine Yeh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Identification of MAPK and mTOR pathway alterations in HER2-amplified colorectal cancer.
First Author: Svea Cheng
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and survival analysis in patients with isolated pulmonary metastases from colorectal cancer (CRC).
First Author: Javier Soto Alsar